N@N

Matthew Harrison Maintained (AMGN) at Hold with Increased Target to $238 on, Feb 9th, 2022

Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Hold with Increased Target from $235 to $238 on, Feb 9th, 2022.

Matthew has made no other calls on AMGN in the last 4 months.

There are 6 other peers that have a rating on AMGN. Out of the 6 peers that are also analyzing AMGN, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Geoff Meacham of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $255 on, Wednesday, January 5th, 2022
• Kennen MacKay of "RBC Capital" Maintained at Hold with Increased Target to $218 on, Tuesday, December 21st, 2021
• Salim Syed of "Mizuho" Maintained at Hold with Decreased Target to $194 on, Monday, November 22nd, 2021
• Evan Seigerman of "BMO Capital" Initiated at Hold and Held Target at $228 on, Friday, November 19th, 2021
• Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $216 on, Wednesday, November 3rd, 2021

This is the rating of the analyst that currently disagrees with Matthew

---

• Salveen Richter of "Goldman Sachs" Initiated at Strong Buy and Held Target at $258 on, Monday, December 6th, 2021

Contributing Sources

---